PAPER Zhou Q
SEARCH RESULTS
337603 RESULTS
PAPER Sapaly D, Cheguillaume F, Weill L, Clerc Z, Biondi O, Bendris S, Buon C, Slika R, Piller E, Sundaram VK, da Silva Ramos A, Amador MD, Lenglet T, Debs R, Le Forestier N, Pradat PF, Salachas F, Lacomblez L, Hesters A, Borderie D, Devos D, Desnuelle C, Rolland AS, Periou B, Vasseur S, Chapart M, Le Ber I, Fauret-Amsellem AL, Millecamps S, Maisonobe T, Leonard-Louis S, Behin A, Authier FJ, Evangelista T, Charbonnier F, Bruneteau G, PULSE study group
Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis.
Brain. 2024 Aug 28; PubMed.Babara Smith
Protheragen
PAPER Schmid B, Prehn KR, Nimsanor N, Garcia BI, Poulsen U, Jørring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Ramakrishna S, Muddashetty R, Steeg R, Bruce K, Mackintosh P, Ebneth A, Holst B, Cabrera-Socorro A
Corrigendum to "Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line" [Stem Cell Res. 34/1873-5061 (2019) 101349-55].
Stem Cell Res. 2020 Oct;48:102005. Epub 2020 Sep 21 PubMed.Tenure-Track Faculty Position with the Wisconsin Registry for Alzheimer’s Prevention (WRAP)
JOB 2024-08-29 Employer University of Wisconsin-Madison Principal Investigator Sterling Johnson Description The University of Wisconsin-Madison invites applications for a tenure-track faculty position with the Wisconsin Registry for Alzheimer’s Prevention (WRAP). This i
Aditya Aundhakar
Self employedMumbai, India
Neurobehavioral Clinical Faculty
JOB 2024-08-29 Employer University of Chicago Contact Sydney.Johnson@bsd.uchicago.edu To be considered, those interested must apply through The University of Chicago‚ Academic Recruitment job board, which uses Interfolio to accept applications: http://apply.interfolio.c
Leqembi: The Case for Long-Term Dosing
CONFERENCE COVERAGE 2024-08-29 Conference Coverage Now that lecanemab has been in clinical use in the U.S. for a little over a year, doctors are asking how long they should treat. This remains an open question. Drug maker Eisai has proposed to the FDA, in a supplemental biological lice
Jonathan Martínez
Universidad de ValparaisoValparaiso, Chile
Sydney Johnson
University of ChicagoChicgao, United States
PAPER Wang Z, Song B, Wang J, Wang X, Tang B
Alzheimer's disease and its family history reduce the risk of non-Hodgkin's lymphoma: A Mendelian randomization study.
Alzheimers Dement. 2024 Aug 27; PubMed.PAPER Velma GR, Laham MS, Lewandowski C, Valencia-Olvera AC, Balu D, Moore A, Ackerman-Berrier M, Rychetsky P, Penton C, Musku SR, Annadurai A, Sulaiman MI, Ma N, J Thatcher GR
Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer's Disease Validated in a Mouse Model Expressing Human APOE3/APOE4.
J Med Chem. 2024 Aug 27; PubMed.PAPER Xing C, Zhang X, Wang D, Chen H, Gao X, Sun C, Guo W, Roshan S, Li Y, Hang Z, Cai S, Lei T, Bi W, Hou L, Li L, Wu Y, Li L, Zeng Z, Du H
Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer's Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis.
Brain Behav Immun. 2024 Aug 25;122:510-526. PubMed.PAPER Sacharczuk M, Mickael ME, Kubick N, Kamińska A, Horbańczuk JO, Atanasov AG, Religa P, Ławiński M
The Current Landscape of Hypotheses Describing the Contribution of CD4+ Heterogeneous Populations to ALS.
Curr Issues Mol Biol. 2024 Jul 23;46(8):7846-7861. PubMed.PAPER Lima VD, Ferreira YG, de Oliveira JC, Raia VA, Rodrigues Emerick LB, Albiero LR, Sinhorin VD, Emerick GL
Alzheimer's Disease Mortality Rate: Correlation with Socio-Economic and Environmental Factors.
Toxics. 2024 Aug 13;12(8) PubMed.Current Filters
No filters selected